LAMA5

Official Full Name

laminin subunit alpha 5

Organism

Homo sapiens

Gene ID

3911

Background

This gene encodes one of the vertebrate laminin alpha chains. Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. The protein encoded by this gene is the alpha-5 subunit of of laminin-10 (laminin-511), laminin-11 (laminin-521) and laminin-15 (laminin-523). [provided by RefSeq, Jun 2013]

Synonyms

BBDS2; NPHS26

Cat.No.	Product Name	Price
CSC-DC008524	Panoply™ Human LAMA5 Knockdown Stable Cell Line	Inquiry
CSC-SC008524	Panoply™ Human LAMA5 Over-expressing Stable Cell Line	Inquiry
CSC-RT2434	Human LAMA5 Knockout Cell Line-Hela	Inquiry

Cat.No.	Product Name	Price
LV16734L	human LAMA5 (NM_005560) lentivirus particles	Inquiry

Cat.No.	Product Name	Price
SHH141455	shRNA set against Mouse Lama5(NM_001081171.2)	Inquiry
SHH141473	shRNA set against Human LAMA5(NM_005560.3)	Inquiry
SHH328247	shRNA set against Human LAMA5 (NM_005560.3)	Inquiry
SHH328251	shRNA set against Mouse LAMA5 (NM_001081171.2)	Inquiry
SHW009499	shRNA set against Danio rerio LAMA5 (NM_001039171)	Inquiry

Cat.No.	Product Name	Price
CDFH010179	Human LAMA5 cDNA Clone(NM_005560.3)	Inquiry
MiUTR1H-05559	LAMA5 miRNA 3'UTR clone	Inquiry
MiUTR1M-06512	LAMA5 miRNA 3'UTR clone	Inquiry
CDCB170974	Danio rerio LAMA5 ORF Clone (NM_001039171)	Inquiry
CDCB181859	Rabbit LAMA5 ORF clone (XM_008253904.1)	Inquiry
CDCR290454	Human LAMA5 ORF Clone(NM_005560.3)	Inquiry

Detailed Information

Recent Progress

The gene LAMA5 encodes laminin-α5, which is an essential component of the glomerular basement membrane. It may be associated with the disease named nephrotic syndrome (NS), which is a chronic kidney disease and characterized by considerable loss of protein in the urine causing hypoalbuminemia and edema. In general, about 10% of childhood-onset cases do not respond to steroid therapy and are classified as steroid-resistant NS (SRNS). In about 25% of cases with SRNS, a causative mutation concerning LAMA5 can be detected in one of monogenic SRNS genes. Also, mice with a hypomorphic mutation in the orthologous gene Lama5 develop proteinuria and hematuria.

There is also another connection with disease. About half of patients with familial microscopic hematuria (FMH) caused by thin basement membrane nephropathy (TBMN) inherit heterozygous mutations in collagen IV genes (COL4A3, COL4A4). Mutations in COL4A5 cause classical X-linked Alport Syndrome, while rare mutations in the LAMA5 have been reported in patients with focal segmental glomerulosclerosis. The phenotypic spectrum of the patients includes hematuria, proteinuria, focal segmental glomerulosclerosis, loss of kidney function and renal cortical cysts. A modifier role of LAMA5 on the background of a hypomorphic Alport syndrome is a possible explanation of these findings. This links a LAMA5 variant with human renal disease and expands the spectrum of genes involved in glomerular pathologies accompanied by familial hematuria. The cystic phenotype overlaps with that of a mouse model, which carried a Lama5 hypomorphic mutation that caused severely reduced Lama5 protein levels and produced kidney cysts.

It has been previously elucidated that mutations in the Fms-related tyrosine kinase 4 (FLT4) and forkhead box protein C2 (FOXC2) genes cause Milroy disease (MD) and lymphedema-distichiasis syndrome (LDS), respectively, however, the mechanism underlying disease pathology remains unclear. Researchers identified four rare variants in the LAMA5 gene, in subjects carrying novel and known missense FLT4 mutations along with duplication and insertion in FOXC2. Significant lymphatic dysfunction was observed in both MD and LDS patients. In the MD patient, tortuous lymphatics in the dorsum of the foot were slowly enhanced. Dilated lymph collectors with disruption and lymph leakage were observed in the familial LDS case. Numerous tortuous lymph collectors were visualized along the entire length of affected lower limbs, and retrograde lymph flow was observed in the lymph collectors in the isolated LDS case. The finding of rare LAMA5 variants together with FLT4 and FOXC2 mutations suggested that these mutations may be co-responsible for these disorders and most likely interfere with the function of lymphatics.

Epithelial-mesenchymal transition (EMT) enhances the migration and invasion of cancer cells, and is regulated by various molecular mechanisms including extracellular matrix metalloproteinase (MMP) activity. Researchers have previously reported that transformation of epithelial Madin-Darby canine kidney (MDCK) cells with oncogenic H-Ras (21D1 cells) induces EMT, and significantly elevates MMP1 expression. It was shown that depletion of MMP1 lowered the ability of the cellular secretome (extracellular culture medium) to influence recipient cell behaviour. It was then revealed that LAMA5 can be a novel biological substrate of MMP1, which generates internal and C-terminal proteolytic fragments in 21D1 secretome (Fig.1). Furthermore, antibody-based inhibition of integrin αvβ3 on endothelial cells nullified the angiogenic capability of 21D1 secretome. Therefore, this could be a new VEGF-independent mechanism in which LAMA5 serves as substrate. This could be employed by oncogenic cells to promote tumour angiogenesis.

Fig. 1. LAMA5 is proteolytically fragmented by MMP1. (a) In silico prediction of MMP1 substrates. (b,c) Immuno-blot analysis of LAMA5 (b), and COL12A1 (c) expression in secretome samples. (Gopal et al, 2016)

References:

Braun, D. A., Warejko, J. K., Ashraf, S., Tan, W., Daga, A., & Schneider, R., et al. (2018). Genetic variants in the lama5 gene in pediatric nephrotic syndrome. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
Voskarides, K., Papagregoriou, G., Hadjipanagi, D., Petrou, I., Savva, I., & Elia, A., et al. (2018). Col4a5 and lama5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect?. Bmc Nephrology, 19(1), 114.
Sampaolo, S., Napolitano, F., Tirozzi, A., Reccia, M. G., Lombardi, L., & Farina, O., et al. (2017). Identification of the first dominant mutation of lama5 gene causing a complex multisystem syndrome due to dysfunction of the extracellular matrix. Journal of Medical Genetics.
Bartolini, A., Cardaci, S., Lamba, S., Oddo, D., Marchiò, C., & Cassoni, P., et al. (2016). Bcam and lama5 mediate the recognition between tumor cells and the endothelium in the metastatic spreading of kras mutant colorectal cancer. Clinical Cancer Research An Official Journal of the American Association for Cancer Research, 22(19), 4923.
Gopal, S. K., Greening, D. W., Zhu, H. J., Simpson, R. J., & Mathias, R. A. (2016). Transformed mdck cells secrete elevated mmp1 that generates lama5 fragments promoting endothelial cell angiogenesis. Scientific Reports, 6.

Quick Inquiry